Abstract:Objective: To explore the rule of proliferation of T lymphocyte subsets in patients with clinical asthma remission and the molecular mechanism. Methods: Peripheral blood samples were collected from 15 asthmatic patients, 15 asthmatic patients in clinical remission, and 15 healthy control subjects, all sex-, and age-matched. CD(4)(+) T and CD(8)(+) T lymphocytes were isolated. Flow cytometry was used to examine the cell cycles of CD(4)(+) T and CD(8)(+) T lymphocytes. Fluorescence immunohistochemistry was used to detect the expression levels of cell cycle regulatory proteins (CCRPs), including cyclin D, cyclin E, and P27(kip1), PI3K, and STAT6. Results: (1) The percentage of G(0)/G(1) phase of the CD(4)(+) T lymphocytes of the asthmatic patients was 82.00%, significantly lower than those of the asthmatic patients in clinical remission and healthy controls (92.50% and 99.00%, Z = 12.35, P < 0.01). The percentage of S phase of the CD(4)(+) T lymphocytes of the asthmatic patients was 18.00%, significantly higher than those of the asthmatic patients in clinical remission and healthy controls (6.10% and 0.20% respectively, Z = 8.05, P < 0.05). The percentage of G(2)/M phase of the CD(4)(+) T lymphocytes of the asthmatic patients was 2.80%, significantly higher than those of the asthmatic patients in clinical remission and healthy controls (0.40% and 0 respectively, Z = 9.16, P < 0.05). The S + G(2)/M phase of the CD(4)(+) T lymphocytes of the asthmatic patients was 18.00%, significantly higher than those of the asthmatic patients in clinical remission and healthy controls (7.50% and 0.20% respectively, Z = 12.80, P < 0.05). The distribution of G(0)/G(1) phase of CD(8)(+) T lymphocyte of the asthmatic patients was 44.60%, significantly lower than those of the asthmatic patients in clinical remission and healthy controls (95.90% and 100.00% respectively, Z = 21.60, P < 0.01). The distribution of S phase of CD(8)(+) T lymphocytes of the asthmatic patients was 51.70%, significantly lower than those of the asthmatic patients in clinical remission and healthy controls (0.80% and 0 respectively, Z = 25.22, P < 0.01). The distribution of S + G(2)/M phase of the CD(8)(+) T lymphocytes of the asthmatic patients was 55.40%, significantly higher than those of the asthmatic patients in clinical remission and healthy controls (4.10% and 0 respectively, Z = 21.52, P < 0.01). (2) The expression level of P27(kipl) of the CD(4)(+) T lymphocytes of the asthmatic patients was 13.20%, significant lower than those of the asthmatic patients in clinical remission and healthy controls (38.80% and 47.20% respectively, Z = 10.63, P < 0.01). The expression level of cyclin D of the CD(4)(+) T lymphocyte of the asthmatic patients was 35.00%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (28.20% and 13.10% respectively, Z = 10.66, P < 0.01). The expression level of cyclin E of the CD(4)(+) T lymphocytes of the asthmatic patients was 7.90%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (6.30% and 3.70% respectively, Z = 6.64%, P < 0.05). The expression level of P27(kipl) of the CD(8)(+) T lymphocyte of the asthmatic patients was 4.50%, significant lower than those of the asthmatic patients in clinical remission and healthy controls (33.80% and 46.30% respectively, Z = 9.30, P < 0.05). The expression level of cyclin D of the CD(8)(+) T lymphocyte of the asthmatic patients was 24.20%, not significant different from those of the asthmatic patients in clinical remission and healthy controls (26.10% and 32.20% respectively, Z = 0.09, P > 0.05). The expression level of cyclin E of the CD(8)(+) T lymphocyte of the asthmatic patients was 9.30%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (5.60% and 3.50% respectively, Z = 4.91, P > 0.05). (3) The expression level of PI(3)K-110alpha of the CD(4)(+) T lymphocyte of the asthmatic patients was 7.60%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (6.40% and 3.30% respectively, Z = 9.04, P < 0.05). The expression level of STST()6 of the CD(4)(+) T lymphocyte of the asthmatic patients was 8.20%, significant higher than those of the asthmatic patients in clinical remission and healthy controls (2.70% and 1.90% respectively, Z = 18.08, P > 0.01). The expression levels of PI(3)K-110alpha and STST(6) of the CD(8)(+) T lymphocytes of the asthmatic patients were not significant different from those of the asthmatic patients in clinical remission and healthy controls (Z = 4.91 and 5.70, both P > 0.05). Conclusion: There is excessive proliferation of CD(4)(+) T lymphocytes in the patients with clinical asthma remission, which may be related to the abnormal expression of CCRP (cyclin D, cyclin E, and P27(kip1)), PI(3)K, and STAT(6).

Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma.

MicroRNA in Children with Asthma: Findings from Bronchoalveolar Lavage Fluid

Comparative Analysis of the Role of CD4+ and CD8+ T Cells in Severe Asthma Development

Pulmonary Microrna Profiles Identify Involvement of Creb1 and Sec14l3 in Bronchial Epithelial Changes in Allergic Asthma

Single-cell transcriptomic analysis reveals key immune cell phenotypes in the lungs of patients with asthma exacerbation

An increased ratio of Th2/Treg cells in patients with moderate to severe asthma.

Toll-like Receptor 7 Is Reduced in Severe Asthma and Linked to an Altered MicroRNA Profile

Aberrantly expressed lncRNAs identified by microarray analysis in CD4 + T cells in asthmatic patients.

[Cytokine Profiles of CD4(+) T Memory Cells in Asthma and Their Relationship with Asthma Severity].

[Activation Related Genes of Memory CD(4)(+) T Cells in Asthma Patients].

Sputum Transcriptomics Reveal Upregulation of IL-1 Receptor Family Members in Patients with Severe Asthma.

CD4+ CD25+ regulatory T cells and expressions of forkhead/winged helix transcription factor ( Foxp 3 ) mRNA in peripheral blood of patients with asthma

Analysis of CD4 + CD25 + regulatory T cells and Foxp3 mRNA in the peripheral blood of patients with asthma

The Declined CD4+ CD25+Treg Cells in Patients with Moderate to Severe Asthma Associated with Over-Expressed Th2 Response

[Proliferation of T lymphocyte subsets in asthma patients in clinical remission and molecular mechanism thereof]

Activation of CD8+ T Cells in Chronic Obstructive Pulmonary Disease Lung

Single-cell analysis reveals alterations in cellular composition and cell-cell communication associated with airway inflammation and remodeling in asthma

Expression and Functional Analysis of Toll-Like Receptors of Peripheral Blood Cells in Asthmatic Patients: Implication for Immunopathological Mechanism in Asthma

Reduced CCR6+IL-17A+Treg Cells in Blood and CCR6-Dependent Accumulation of IL-17A+Treg Cells in Lungs of Patients With Allergic Asthma

[Research Progress of Non-Coding RNA in Regulating the Function of T Cells in Asthma].

Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma